Jane Street Group, LLC Tyme Technologies, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$0.99 - $1.38 $23,067 - $32,153
-23,300 Reduced 64.36%
12,900 $13,000
Q2 2021

Aug 16, 2021
SELL
$1.14 - $1.87 $45,257 - $74,239
-39,700 Reduced 52.31%
36,200 $46,000
Q1 2021

May 18, 2021
BUY
$1.34 - $3.53 $101,706 - $267,927
75,900 New
75,900 $135,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email